© Endostart
SeaBeLife receives Orphan Drug Designation (ODD) from EMA for treatment of acute liver failure
Carthera receives Orphan Drug Designation from US and EU authorities for carboplatin in malignant glioma
© Carthera
Axoltis Pharma receives authorization to launch SEALS – phase II clinical trial for ALS patients with drug candidate NX210c
©Axoltis
Endostart receives FDA 510(k) clearance for Endorail®, ushering in new era of gastrointestinal endoscopy innovation
© Endostart
Metafora Biosystems secures reimbursement in France for first IVD to help diagnose Glut1 deficiency syndrome
RDS secures CE mark for MultiSense® Remote Patient Monitoring solution
Robocath receives NMPA approval for R-One robotic platform in China
© Robocath
Omini receives EU patent approval for electrochemical based sensor used for multiplexed blood testing platform
© Jérémy Barande – Ecole Polytechnique
Orphelia Pharma secures US patent covering KIZFIZO®, first drinkable formulation of temozolomide
Jeremy Bastid